As the largest provider of experts for complex commercial litigation, IMS ExpertServices has located experts for nearly all of the AmLaw 100 and more than half of the Fortune 100. We are an expert witness provider that specializes in connecting highly credentialed, experienced experts and consultants with the attorneys who need them. By focusing on this niche legal market, we are able to find more qualified experts in less time than it would typically take an attorney.
We're NOT a Registry
Unlike a database of self-proclaimed experts, we employ a rigorous search and vetting process to find and provide the exact expert needed for your case.
There is no risk in having us find and present experts for you. Only after you retain an expert on your case do we place our fee on top of the expert’s hourly rate.
Because of our dedication to service and quality, IMS ExpertServices has consistently shown high-growth. For the last five years, we have ranked on the Inc. 5000 list of fastest growing private companies in America.
Call us to see how our services can make the difference in your next case. 877-838-8464.
Expert Witness Was Free to Change his Mind, 8th Circuit Rules
When an expert has a change of mind about his or her own opinion, what does it mean to the case? A recent decision from the 8th U.S. Circuit Court of Appeals sheds new light on this recurring question. The issue is one that comes up with surprising regularity, sometimes with dramatic consequences.
Riding the Social Media Wave - Ethical Implications
For attorneys previously reluctant to dive into the world of online social media, the benefits of utilizing social networking as part of an effective marketing strategy are now undeniable. Navigating the social media world can be fraught with legal dangers and complex ethical issues unique to the legal profession, and often the rules regulating ethical compliance for attorneys are ambiguous at best.
Could IBM's Watson Make Experts Obsolete?
When IBM's Watson beat two human challengers to win the TV quiz show Jeopardy!, a collective "Wow!" was heard at just how far artificial intelligence has developed.
Joint Defense Pacts Pose Pitfalls
Facing increases in litigation and decreases in legal budgets, corporate defendants in patent and trademark lawsuits are more regularly employing a tactic most would not have dreamed of a decade ago. Rather than fight these cases single-handedly, they are joining together and hiring a single law firm to represent them as a group.
Rule 26: Major Changes For Attorneys and Experts
A major revision to the federal rules governing expert witness reports is on track to take effect in December. Lawyers and experts alike agree that the changes are long overdue.
The 2010 Expert Forecast: Surge Ahead
The New Year has barely begun, but all indications suggest 2010 will bring a surge in litigation involving major corporations. With that surge will come increasing demand for expert witnesses across a range of business-to-business disputes
The Top 10 Expert Rulings of 2009
As 2009 drew close to its end, the Supreme Court turned down an opportunity to decide a case many lawyers believed could set new precedent regarding the admissibility of expert testimony. But earlier in the year, in a key criminal case, the court affirmed the right of a defendant to confront experts who prepare prosecution evidence
Supreme Court to Review Controversial Patent Ruling
It is déjà vu all over again, as the Supreme Court once again has agreed to review a controversial patent ruling of the Federal Circuit Court of Appeals. The issue this time: whether a patent owner's rights were exhausted by a license agreement and subsequent sale of product pursuant to the license.
For Ronald Katz, Patent Litigation Pays Billions
Ronald A. Katz once predicted that he would someday become the wealthiest patent holder ever. By most estimates, he has achieved that goal – or will soon.
Daubert Ruling Could Severely Curtail Celebrex Cases
A federal judge's decision to exclude expert testimony may force hundreds of plaintiffs to drop their claims against Pfizer Inc. that the anti-inflammatory drug Celebrex caused them to suffer heart attacks or strokes.
Daubert Ruling Fuels Thimerosal Debate
A federal court ruling excluding all expert testimony that the drug-preservative thimerosal caused a minor child's autism is likely to have repercussions well beyond the case in which it came
Stefan Boedeker, a Director with Berkeley Research Group, LLC (BRG,) specializes in the application of Economic, Statistical, and Financial Models to a variety of areas such as solutions to business issues, economic impact studies, and complex litigation cases.
